Modern therapy of young and adult Ph-ALL.

about

Modern therapy of young and adult Ph-ALL.

Item

http://www.wikidata.org/entity/Q40817792

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Modern therapy of young and adult Ph-ALL.

@en

type

Item

label

Modern therapy of young and adult Ph-ALL.

@en

prefLabel

Modern therapy of young and adult Ph-ALL.

@en

P1476

Modern therapy of young and adult Ph-ALL.

@en

P2093

A Rambaldi

http://www.w3.org/2001/XMLSchema#string

E Oldani

http://www.w3.org/2001/XMLSchema#string

O Spinelli

http://www.w3.org/2001/XMLSchema#string

R Bassan

http://www.w3.org/2001/XMLSchema#string

T Intermesoli

http://www.w3.org/2001/XMLSchema#string

P2860

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

Modern therapy of acute lymphoblastic leukemia.

Improved risk classification for risk-specific therapy based on the molecular study of minimal residual disease (MRD) in adult acute lymphoblastic leukemia (ALL).

CD20 expression has no prognostic role in Philadelphia-negative B-precursor acute lymphoblastic leukemia: new insights from the molecular study of minimal residual disease.

Pediatric-inspired therapy in adults with Philadelphia chromosome-negative acute lymphoblastic leukemia: the GRAALL-2003 study.

In adults with standard-risk acute lymphoblastic leukemia, the greatest benefit is achieved from a matched sibling allogeneic transplantation in first complete remission, and an autologous transplantation is less effective than conventional consolid

Targeted therapy with the T-cell-engaging antibody blinatumomab of chemotherapy-refractory minimal residual disease in B-lineage acute lymphoblastic leukemia patients results in high response rate and prolonged leukemia-free survival.

Clinical significance of minimal residual disease quantification in adult patients with standard-risk acute lymphoblastic leukemia.

P2888

leusup.2012.6

P304

S5-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/LEUSUP.2012.6

http://www.w3.org/2001/XMLSchema#string

P433

Suppl 2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-08-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1010167119

http://www.w3.org/2001/XMLSchema#string

P698

27175250

http://www.w3.org/2001/XMLSchema#string

P932

4851211

http://www.w3.org/2001/XMLSchema#string

Modern therapy of young and adult Ph-ALL.

about

Modern therapy of young and adult Ph-ALL.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P932